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Accurately distinguishing between different degenerative dementias during life is challenging but increasingly important with the
prospect of disease-modifying therapies. Molecular biomarkers of dementia pathology are becoming available, but are not widely
used in clinical practice. Conversely, structural neuroimaging is recommended in the evaluation of cognitive impairment. Visual
assessment remains the primary method of scan interpretation, but in the absence of a structured approach, diagnostically relevant
information may be under-utilized. This deﬁnitive, multi-centre study uses post-mortem conﬁrmed cases as the gold standard to: (i)
assess the reliability of six visual rating scales; (ii) determine their associated pattern of atrophy; (iii) compare their diagnostic value
with expert scan assessment; and (iv) assess the accuracy of a machine learning approach based on multiple rating scales to predict
underlying pathology. The study includes T1-weighted images acquired in three European centres from 184 individuals with
histopathologically conﬁrmed dementia (101 patients with Alzheimer’s disease, 28 patients with dementia with Lewy bodies, 55
patients with frontotemporal lobar degeneration), and scans from 73 healthy controls. Six visual rating scales (medial temporal,
posterior, anterior temporal, orbito-frontal, anterior cingulate and fronto-insula) were applied to 257 scans (two raters), and to a
subset of 80 scans (three raters). Six experts also provided a diagnosis based on unstructured assessment of the 80-scan subset. The
reliability and time taken to apply each scale was evaluated. Voxel-based morphometry was used to explore the relationship
between each rating scale and the pattern of grey matter volume loss. Additionally, the performance of each scale to predict
dementia pathology both individually and in combination was evaluated using a support vector classiﬁer, which was compared
with expert scan assessment to estimate clinical value. Reliability of scan assessment was generally good (intraclass correlation
coefﬁcient 4 0.7), and average time to apply all six scales was 53min. There was a very close association between the pattern of
grey matter loss and the regions of interest each scale was designed to assess. Using automated classiﬁcation based on all six rating
scales, the accuracy (estimated using the area under the receiver-operator curves) for distinguishing each pathological group from
controls ranged from 0.86–0.97; and from one another, 0.75–0.92. These results were substantially better than the accuracy of any
single scale, at least as good as expert reads, and comparable to previous studies using molecular biomarkers. Visual rating scores
from magnetic resonance images routinely acquired as part of the investigation of dementias, offer a practical, inexpensive means
of improving diagnostic accuracy.
1 Dementia Research Centre, University College London Institute of Neurology, London WC1N 3BG, UK
2 Neurology Unit, Department of Physiopathology and Transplantation, University of Milan, Fondazione Ca` Granda, IRCCS
Ospedale Policlinico, Milan, Italy
3 Department of Radiology and Nuclear Medicine, VU University Medical Centre, 1081 HZ Amsterdam, The Netherlands
4 Alzheimer Centre, VU University Medical Centre, 1081 HZ Amsterdam, The Netherlands
doi:10.1093/brain/aww005 BRAIN 2016: Page 1 of 15 | 1
Received June 26, 2015. Revised November 30, 2015. Accepted December 04, 2015.
 The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
 Brain Advance Access published March 1, 2016
 by guest on M
arch 11, 2016
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
5 Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK
6 Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
7 Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London WC1N 3BG, UK
8 FMRIB Centre, Nufﬁeld Department of Clinical Neurosciences, University of Oxford OX3 9DU, UK
Correspondence to: Dr Jonathan Schott,
Dementia Research Centre,
University College London Institute of Neurology,
8-11 Queen Square,
London WC1N 3BG,
UK,
E-mail: j.schott@ucl.ac.uk
Keywords: brain atrophy; dementia; MRI; neuropathology; visual rating
Abbreviations: AC = anterior cingulate; AUC = area under the receiver-operator characteristic curve; DLB = dementia with Lewy
bodies; FI = fronto-insula; FTLD = frontotemporal lobar degeneration; ICC = intraclass correlation coefﬁcient; ICC(2,1) = two-way
single measures ICC; ICC(2,k) = two-way average measures ICC based on k raters; MTA = medial temporal lobe atrophy; OF =
orbito-frontal; PA = posterior atrophy; SVC = support vector classiﬁer
Introduction
Distinguishing between the different neurodegenerative
causes of dementia is vitally important to allow affected
individuals and their families to access appropriate treat-
ment, support and care (Gaugler et al., 2013). This require-
ment will become even more pressing as disease-modifying
therapies become available. With the exception of rare
autosomal dominant forms of dementia, accurate diagnosis
during life can be challenging, as distinct underlying pathol-
ogies can result in overlapping clinical symptoms (Schott
and Warren, 2012). Post-mortem examination of brain
tissue, therefore, currently remains the diagnostic gold
standard (Beach et al., 2012). Pathologically, the degenera-
tive dementias are linked by protein misfolding in the brain,
with the speciﬁc abnormal protein and its pattern of depos-
ition deﬁning each neurodegenerative disease. These include
the accumulation of hyperphosphorylated tau and extracel-
lular deposition of amyloid-b in Alzheimer’s disease
(Hyman et al., 2012); the aggregation of alpha-synuclein
in dementia with Lewy bodies (DLB) (McKeith et al.,
2005); and the accumulation of several proteins including
3-repeat and 4-repeat tau, and TAR DNA-binding protein
43 (TDP-43) in frototemporal lobar degeneration (FTLD)
(Mackenzie et al., 2010). Whilst biomarkers of the molecu-
lar pathology of Alzheimer’s disease, including CSF analysis
of amyloid-b, tau and phosphorylated tau (Ewers et al.,
2015), or amyloid PET (Jack et al., 2013), are available
in some expert centres, logistical challenges and ﬁnancial
constraints limit their adoption into routine clinical use at
this time. By contrast, structural neuroimaging is widely
available and recommended as part of the clinical evalu-
ation in all patients with suspected dementia [National
Collaborating Centre for Mental Health (UK), 2006] and
in the diagnostic criteria for a number of different demen-
tias (Hort et al., 2010; Gorno-Tempini et al., 2011;
Rascovsky et al., 2011). The high resolution and excellent
tissue contrast afforded by MRI in particular allows for
global and regional cerebral atrophy to be assessed, offer-
ing positive predictive value for underlying disease path-
ology (Harper et al., 2014).
While a number of sophisticated methods of analysis are
available to quantify global and regional atrophy from
MRI (Dale et al., 1999; Leung et al., 2011; Cardoso et
al., 2013; Schrouff et al., 2013), relatively little progress
has been made to integrate these into clinical work streams
due to special hardware requirements, prohibitively long
processing times and dependency on speciﬁc acquisition
techniques. Accordingly, visual scan assessment remains
the primary method for extracting diagnostically useful in-
formation in clinical settings. However, without oper-
ational guidelines to identify, report or interpret patterns
of atrophy with diagnostic value in dementia, much poten-
tially relevant information may be under-utilized. Visual
rating scales, speciﬁcally designed to assess general and
focal cerebral atrophy in patients with cognitive impair-
ment (reviewed in Harper et al., 2015), may provide such
a framework, allowing for the reliable identiﬁcation and
interpretation of imaging ﬁndings of value in the differen-
tial diagnosis of dementia. Furthermore, since visual rating
scales are both quick and easy to apply, and can be per-
formed on routinely acquired images, they offer an inex-
pensive means of extracting this information, ideally suited
for implementation into clinical practice, and may make it
easier for clinicians without expertise in neuroradiology to
extract diagnostically useful information.
Several visual rating scales have been developed speciﬁc-
ally to rate brain regions vulnerable to atrophy in a range
of different dementias. While some have been used exten-
sively in both research and clinical settings, most notably
the Scheltens’ medial temporal lobe scale (Scheltens et al.,
1992), many have only been evaluated in small single
centre studies. Few studies have attempted to compare dir-
ectly or to combine the diagnostic value of individual
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scales. Fewer still have used a large multi-centre setting to
determine the real-world generalizability and robustness of
such ﬁndings, and to our knowledge, no study has exclu-
sively assessed their diagnostic utility when applied to scans
acquired from individuals with pathologically conﬁrmed
dementias. Using structural magnetic resonance scans
from healthy individuals and a large sample of patients
with a histopathological diagnosis of dementia, this study:
(i) evaluates the reliability of six different visual rating
scales and the time taken to perform these ratings; (ii) ex-
plores the relationship between each visual rating scale and
the pattern of grey matter volume loss; (iii) compares the
performance of rating scales to expert scan assessment in
predicting underlying pathology; and (iv) determines
whether a machine learning (support vector) approach,
based on all visual rating scale scores, can improve predic-
tion accuracy.
Materials and methods
Study population
Patients were identiﬁed who had a diagnosis of dementia
during life and post-mortem (n = 177) or a biopsy conﬁrm-
ation of the underlying pathology (n = 7). Of these, 101 pa-
tients had a primary pathology diagnosis of Alzheimer’s
disease [73 early-onset (565 years at symptom onset), 28
late-onset (565 years at symptom onset)], 28 patients were
diagnosed with DLB, and 55 with FTLD (24 tauopathies, 28
TDP-43 proteinopathies and three with fused-in sarcoma pro-
teins). Pathological examination of brain tissue was carried out
between 1997 and 2013 according to standard histopatholo-
gical processes and criteria in use at the time of assessment at
one of four centres: (i) the Queen Square Brain Bank, London;
(ii) Kings College Hospital, London; (iii) VU Medical Centre,
Amsterdam; and (iv) the Institute for Ageing and Health,
Newcastle. Cognitively normal control subjects (n = 73) were
also included in the study. Ethical approval for the study was
obtained from the National Research Ethics Service Committee
London – South East.
Structural MRI
All individuals had T1-weighted volumetric MRI performed
during life. As the data were collected retrospectively from
multiple centres, the images were acquired on scanners from
three different manufacturers (Philips, GE, Siemens) using a
variety of different imaging protocols. Magnetic ﬁeld strength
varied between 1.0 T (n = 21 scans), 1.5 T (n = 204 scans) and
3.0 T (n = 32 scans). For assessments, images were viewed
using the in-house MIDAS (Medical Image Display and
Analysis Software) image viewer (Freeborough et al., 1997),
which allows for images to be viewed in axial, coronal and
sagittal orientations, and for contrast and zoom to be altered.
Visual rating of cerebral atrophy
Visual rating of the complete imaging dataset of all patients
and controls (n = 257) was performed, blind to all clinical and
pathological information, by two trained raters (G.F. and
L.H.). Three regions were rated based on existing scales pre-
viously described in the literature: (i) the ﬁve-point anterior
temporal (AT) scale by Davies et al. (2006) and Kipps et al.
(2007); (ii) the ﬁve-point medial temporal lobe atrophy (MTA)
scale by Scheltens et al. (1992), previously recommended in the
research guidelines for the diagnosis of Alzheimer’s disease
(Dubois et al., 2007); and (iii) the four-point posterior atrophy
(PA) scale by Koedam et al. (2011). To provide additional,
more ﬁne-grained assessment of anterior atrophy, we used an
adapted and simpliﬁed version of a visual rating scale origin-
ally devised by Davies et al. (2009), as described by Fumagalli
et al. (2014). In brief, three regions—orbito-frontal (OF), an-
terior cingulate (AC) and fronto-insula (FI)—previously shown
to have potential for differential diagnosis (Davies et al., 2009;
Hornberger et al., 2010; Ambikairajah et al., 2014) were se-
lected. To improve usability, each scale was simpliﬁed to four
points and reference images were devised. To improve consist-
ency, slice selection was speciﬁed, with the OF and AC regions
both rated on the ﬁrst anterior slice where the corpus callosum
becomes visible, and the FI rated over three slices, starting on
the ﬁrst anterior slice where the anterior cingulate becomes
visible and moving posteriorly. Images were rated in native
space, in keeping with standard clinical reads. To aid rating
consistency, reference images for each rating scale were pro-
vided to the raters (examples provided in Fig. 1 and provided
in full in the Supplementary material). Separate scores were
recorded for regions in left and right hemispheres. L.H. and
G.F. initially performed visual rating training, applying the
protocol described above to a sample of 150 images (50 con-
trols, 100 with a clinical diagnosis of dementia) from research
participants who attended the Dementia Research Centre,
London.
To provide independent validation of the results from the
two primary raters, two visual rating experts (F.B. and P.S.)
also assessed 80 scans (20 Alzheimer’s disease, 20 DLB, 20
FTLD, 20 control) drawn at random from the total study
population. G.F. also re-rated this subset population. The
time taken by each rater to apply the visual rating protocol
to each image was automatically recorded to estimate the feasi-
bility of implementing such a protocol in clinical practice.
Expert diagnosis
Six clinical dementia experts (F.B., N.F., J.O., P.S., J.S., G.F.),
each provided what they thought was the most likely path-
ology diagnosis for the above-mentioned subset study popula-
tion (n = 80) based on independent, unstructured visual
assessment of each MRI. Experts were blinded to all clinical
and pathological information except the person’s age at the
time of scanning. Images were displayed in a random sequence
in terms of underlying pathology.
Voxel-based morphometry
To explore the relationship between each rating scale and pat-
tern of grey matter volume loss, voxel-based morphometry
preprocessing and analysis was performed using SPM12b
(Statistical Parametric Mapping, Version 12b revision 5829;
http://www.ﬁl.ion.ucl.ac.uk/spm) and Matlab version R2012a
(7.14.0.739 - 64-bit, uk.mathworks.com/products/matlab/).
Due to the variability in scanning parameters, an initial rigid
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registration to the Montreal Neurological Institute
International Consortium for Brain Mapping 152 (ICBM152)
template was performed using the Reg-Aladin tool from the
NiftyReg package (Ourselin et al., 2001; Modat et al., 2010)
to provide a better starting point for the statistical parametric
mapping preprocessing pipeline. Each registration was then
checked and manually adjusted (if necessary) such that the
anterior commissure was within a few millimetres of the
origin and the orientation was within a few degrees of the
ICBM152 template. Grey matter, white matter and CSF were
obtained using the uniﬁed segmentation approach (Ashburner
and Friston, 2005), which includes bias correction (regulariza-
tion = 0.001, full-width at half-maximum = 60mm) and rigid
registration to the ICBM152 template. A group average tissue
probability map was generated through iterative alignment of
the initial segmentations to an evolving estimate of their
group-wise average using the Dartel toolbox (Ashburner,
2007; Ashburner and Friston, 2009). The initial grey and
white matter segmentations were then warped using the
Dartel transformations and modulated to account for local
volume changes, then smoothed with a 6mm full-width at
half-maximum Gaussian kernel.
Statistical analysis
Inter-rater reliability of each rating scale was determined using
the intraclass correlation coefﬁcient (ICC). As described by
Shrout and Fleiss (1979), there are several forms of ICC,
with the appropriate form determined by the underlying stat-
istical model and the intended application of the reliability
results. In this study, a two-way random, absolute, single-
measures ICC [ICC(2,1)] was used to estimate the reliability
Figure 1 Correlation between grey matter volume and visual rating score. Voxel-based morphometry images demonstrating negative
partial correlation between grey matter volume and each visual rating scale, adjusted for the other scales (Y = bACXAC + bOFXOF + bATXAT +
bFIXFI + bMTAXMTA + bPAXPA + bAgeXAge + bGenderXGender + bTIVXTIV + b1TX1T + b3TX3T + bLondonXLondon + bAmsterdamXAmsterdam + m + e).
In all images statistical significance of correlations was corrected for multiple comparisons (family wise error rate P5 0.05). The corresponding
visual rating scale reference images are displayed adjacent to each statistical parametric map. R indicates the right hemisphere.
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of each scale when applied by a single rater. ICC(2,1) was
calculated separately for the subset group (n = 80) based on
four raters (F.B., G.F., P.S., L.H.), and the total study popu-
lation (n = 257) based on two raters (G.F., L.H.). Average
measures ICCs [ICC(2,k)] were also calculated to estimate
the improvement in reliability of each scale when based on
average scores from multiple raters.
Partial correlation of grey matter volume with mean visual
rating scores [based on the mean scores from four raters (F.B.,
G.F., L.H., P.S.) in the subset population and two raters (G.F.,
L.H.) in the remainder of the total population] was assessed by
applying the general linear model at the level of each voxel
using all images (n = 257). Left and right hemisphere scores
were averaged for each scale such that grey matter volume
was modelled as a function of the six rating scales (OF, AC,
AT, FI, MTA, PA) and adjusted for age, gender, total intra-
cranial volume, magnetic ﬁeld strength and acquisition site by
including these variables as covariates in the model (equation
included in Fig. 1). Six additional models were also created to
investigate simple correlation of each individual scale with grey
matter volume, including the covariates described in the larger
model. A mask was created, based on the optimal threshold of
the group average image, using the automatic mask creation
strategy in the statistical parametric mapping toolbox
(Ridgway et al., 2009). Correction for multiple comparisons
was made by using random ﬁeld theory to control the family-
wise error rate at a signiﬁcance level of 0.05.
Expert rater diagnosis was assessed for each binary disease
group comparison and reported in terms of sensitivity, speci-
ﬁcity and balanced accuracy [0.5  (sensitivity + speciﬁcity)].
Analysis of the visual rating scale data, at the level of the
individual scale and when the scales are combined in a linear
support vector classiﬁer, was based on the average scores
across raters for each image in the study population (four
rater average for the 80-scan subset, two rater average for
the remaining scans). Left and right hemisphere scores were
then averaged to create a mean score per visual rating scale
(i.e. six scores per image), however, supplementary analysis
was also performed based on the individual hemisphere
scores (i.e. 12 scores per image) (Supplementary Fig. 1).
Group separation was investigated at the level of primary
pathology group (Alzheimer’s disease, DLB, FTLD and con-
trol), and additionally at the subgroup level [early- (565
years at symptom onset), and late-onset Alzheimer’s disease,
DLB, FTLD-Tau, FTLD-TDP43, younger controls (565 years
at the time of scanning) and older controls].
The ability of each visual rating scale to predict pathology
was assessed for each binary disease group comparison and
reported in terms of sensitivity, speciﬁcity, balanced accuracy
and area under the receiver-operator characteristic curve
(AUC). Independent left and right hemisphere analysis was
based on the highest of the two scores in all cases.
Separate linear support vector classiﬁers (SVC) were used to
predict pathology for each binary comparison. Scores (features)
were corrected for age at the time of scanning. Split-half separ-
ation was used to divide the data for each classiﬁer into training
and testing sets. The training data were scaled to zero mean and
unit variance over subjects, with the same transformation then
applied to the testing data. SVCs were trained using leave-one-
out cross-validation on the training set. Class weighting was
applied to adjust for unbalanced groups. The regularization par-
ameter, C, was optimized using grid-search in the range
1  105 to 100, increasing by an order of magnitude each
time. The SVC was implemented using the squared-hinge loss
function and L2 regularization, with the algorithm set to solve
the primal optimization problem. Classiﬁcation accuracy is pre-
sented as balanced accuracy and receiver operator characteristic
AUC values. Feature weighting for each classiﬁer is discussed as
an indication of each scale’s contribution to group separation
(Rakotomamonjy, 2003).
All data processing and analyses were performed using
Python libraries NumPy 1.8.1 (van der Walt et al., 2011),
SciPy 0.14.0 (Jones et al., 2001) and Pandas 0.14.1
(McKinney, 2010) on Python 2.7.6 – 64-bit. SVC processing
and analysis was performed using the Python libraries SciPy
0.14.0 (Jones et al., 2001) and Scikit-Learn 0.15.2 (Pedregosa
et al., 2011). Conﬁdence intervals were calculated using the
Hanley-McNeil approach evaluated in Newcombe (2006).
Results
Demographics
Demographic details of the patients and control subjects are
shown in Table 1. In terms of the primary groups
(Alzheimer’s disease, DLB, FTLD and control), there were
no signiﬁcant differences between gender, disease duration
and total intracranial volume. The patients with DLB were
signiﬁcantly older (P5 0.001), with less time between scan
until death (P5 0.05) than the patients with Alzheimer’s
disease and FTLD. The control subjects were also signiﬁ-
cantly older than the patients with Alzheimer’s disease or
FTLD (P5 0.05). Mini-Mental State Examination (MMSE)
within 6 months of scan date was only available in 116 of
the 184 patients (missing data in 37/101 Alzheimer’s disease,
5/28 DLB, 26/55 FTLD). Based on the data available,
MMSE was signiﬁcantly higher in the FTLD than the
Alzheimer’s disease group (P5 0.001). Similar results were
found when using MMSE closest to scan (n = 170/184).
In terms of the age-matched subgroups, the group of pa-
tients with late-onset Alzheimer’s disease was signiﬁcantly
older than the DLB group (P50.05), with less time from
scan until death (P5 0.001). The group of patients with
early-onset Alzheimer’s disease was signiﬁcantly younger
than the FTLD-Tau (P5 0.001) and the FTLD-TDP43
(P5 0.05) groups. They also scored signiﬁcantly lower
than the FTLD-Tau group on the MMSE (P50.001).
Expert diagnoses based on
unstructured visual scan assessment
The mean sensitivity, speciﬁcity and balanced accuracy of
expert diagnosis based on standard, unstructured assess-
ments of the images are shown in Table 2. Balanced accur-
acy was high (90%) for distinguishing Alzheimer’s disease
and FTLD from controls, and 70% for DLB. For the
more clinically relevant head-to-head disease comparisons
balanced accuracy was on the order of 70–80% balanced
accuracy for the multiple disease group comparisons was
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60–70%, with speciﬁcities of 69–86%, but sensitivities
were more variable, ranging from 34–67%.
Time to perform visual rating
Mean time to perform and record all six visual rating scales
based on three raters assessing the subset study population
(n = 80) was 2.9  1.3min. Individual rater means and
standard deviations were 2.7  1.1, 2.4  1.0 and
3.6  1.6min.
Inter-rater reliability of visual rating
scores
Single measure and average measure ICC results for each
scale are shown in Supplementary Table 1. For the single
measures ICC values, representing the reliability of each
scale at the level of the individual rater, the MTA scale per-
formed best overall, with very similar results achieved with
two raters assessing all 257 scans, and four raters scoring 80
scans [ICC(2,1)5 0.79]. The PA, OF and FI scales also
demonstrated good reliability [ICC(2,1)50.71] based on
two raters assessing the total study population; reliability
was slightly reduced when performed by four raters in the
subset population [ICC(2,1)5 0.58]. The reliability of the
AC scale was lowest overall [ICC(2,1) range = 0.49–0.62].
As expected, the reliability based on mean rater scores was
consistently greater for all scales [ICC(2,k)50.73]. There
were no material differences in reliability based on the
larger or smaller population samples for any scale with the
exception of the AT and AC scales, which were less reliable in
the larger population sample.
Correlation of grey matter volume
with visual rating scores
Voxel-based morphometry analysis revealed a negative par-
tial correlation of higher visual rating score with lower grey
matter density for all visual rating scales. As shown in Fig. 1,
the pattern of regional atrophy correlated very closely with
the speciﬁc brain region each scale was designed to assess.
This regional speciﬁcity was highest for the MTA scale, al-
though even the smaller frontal regions (OF and AC) showed
signiﬁcant correlation with their visual rating scales. Only the
AT scale demonstrated a small region in the left superior par-
ietal lobule/supramarginal gyrus where visual rating scores
were positively correlated with grey matter atrophy (i.e. the
reverse contrast; Supplementary Fig. 2). As higher AT scores
are associated with FTLD pathologies, and in particular
TDP43-C pathology associated with semantic dementia
(Whitwell et al., 2010; Rohrer et al., 2011), which are less
likely to demonstrate atrophy in posterior brain regions, this
result is pathologically plausible. As expected, analysis of
each scale in separate models demonstrated a more diffuse
pattern of atrophy, although, the most highly correlated re-
gions were conﬁned to, or included, the brain region targeted
by each scale (Supplementary Fig. 3).
Mean visual rating scores per pathol-
ogy group
The groups of patients with Alzheimer’s disease and FTLD
both had signiﬁcantly higher scores than the control group
for all visual rating scales (P5 0.05 AC in the Alzheimer’s
disease comparison, P5 0.001 all other). The FTLD group
also had signiﬁcantly higher scores than the Alzheimer’s
disease and DLB groups in all but the PA scale
(P5 0.001). Differences between the DLB and control
groups did not reach signiﬁcance for the AC and PA
scales. The MTA scores for the DLB group were signiﬁ-
cantly lower than the Alzheimer’s disease group (P50.05).
In terms of the age-matched subgroup comparisons, the
young control group had signiﬁcantly higher scores that the
groups of patients with early-onset Alzheimer’s disease and
FTLD (P50.001, P50.05 PA in the FTLD comparisons).
The FTLD-Tau group had signiﬁcantly higher scores than
the early-onset Alzheimer’s disease and DLB groups in all
but the PA scale (P5 0.05), and the late-onset Alzheimer’s
disease group in the frontal scales only (P50.001 AC,
P5 0.05 OF, FI). The FTLD-TDP43 group had signiﬁ-
cantly higher scores than the early-onset Alzheimer’s dis-
ease and DLB groups based on the OF, AT and MTA
scales (P5 0.05), and the late-onset Alzheimer’s disease
group based on the AC and AT scales (P50.05). The
late-onset Alzheimer’s disease group had signiﬁcantly
higher scores than the older controls in the OF, AT
(P5 0.05), and MTA scales (P5 0.001). The late-onset
Alzheimer’s disease group also had signiﬁcantly higher
scores than the DLB group in the MTA scale (P5 0.05).
Pathology classification accuracy for
each visual rating scale
The results for the best performing scale for each group
comparison are summarized in Table 2. The MTA scale
was most effective at accurately identifying Alzheimer’s dis-
ease pathology from the control group (AUC = 0.82) and
the DLB group (AUC = 0.67). Higher PA scale scores
(52.5) added some value in comparisons with the FTLD
group, although sensitivity was low (22%). The OF scale
was useful for distinguishing DLB from the control group
(AUC = 0.74). All other scales were at chance for detecting
DLB from the other disease groups. The MTA scale was
the most effective at identifying FTLD pathology when
compared with the control group (AUC = 0.92) and the
DLB group (AUC = 0.81). Higher OF scale scores (52.5)
were speciﬁc for FTLD pathology (81%) when compared
with the Alzheimer’s disease group (AUC = 0.73).
Subgroup analysis is presented in Table 3. Using age-
matched controls improved accuracy in all comparisons
except DLB versus older controls, which was slightly
reduced (AUC = 0.74 to 0.70). In the early-onset
Alzheimer’s disease versus younger control group, the FI
scale was the single best scale for distinguishing between
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the groups, although the PA scale also performed well (cut-
off = 1.5, AUC = 0.85). Otherwise, the PA scale was best
for accurately identifying early-onset Alzheimer’s disease
from the other groups, with the optimal cut-off varying
by comparison. The MTA scale was the best single scale
for identifying late-onset Alzheimer’s disease, performing
well in the comparison with the DLB group (AUC =0.79),
although at chance for the comparisons with the FTLD
groups (FTLD-Tau: AUC = 0.50, FTLD-TDP43: AUC =
0.45). Accuracy based on the highest left/right score
rather than mean produced similar results, which are pre-
sented in Supplementary Table 2.
Support vector classification
accuracy for pathology based on
visual rating scores
The results for each group comparison using the mean
right/left scores (i.e. six features) are summarized in
Table 2 and illustrated in Fig. 2. For all comparisons, the
balanced accuracy ranged from 68–93%, and AUC from
0.67–0.97. SVC classiﬁcation accuracy demonstrated a sub-
stantial improvement over the best single score in all cases,
equivalent to or better than expert diagnosis. Based on the
feature weighting applied by each SVC, the MTA, PA and
AT scales contributed most to the separation of the
Alzheimer’s disease group from controls, and the OF and
AT scales contributed most to the separation of the DLB
group from controls. With the exception of the PA scale,
most scales contributed equally to the separation of the
FTLD group from the controls. The PA (indicating
Alzheimer’s disease), AT and OF scales (indicating FTLD)
contributed most to the separation of the Alzheimer’s dis-
ease and FTLD groups. All scales except the PA scale con-
tributed similarly to the separation of DLB and FTLD,
weighted towards the FTLD group.
SVC accuracy based on the subgroup analysis is pre-
sented in Table 3. In most cases the SVC improved the
classiﬁcation accuracy over the single scale, however, in
some cases particularly comparisons involving the FTLD-
Tau group the accuracy was reduced. Feature weighting for
each SVC is displayed in Supplementary Table 3. SVC per-
formance based on individual left and right-sided hemi-
sphere scores for each scale (12 features) are presented in
Supplementary Table 2, this improved the classiﬁcation ac-
curacy in 4 of the 10 SVCs that underperformed in com-
parison with the single scale (late-onset Alzheimer’s disease
from DLB, DLB from (older) controls, FTLD-Tau from
FTLD-TDP43, FTLD-TDP43 from FTLD-Tau).
Discussion
This large, multi-centre study of pathologically proven de-
mentias demonstrates that visual rating scales from rou-
tinely acquired structural MRIs are fairly reliable and
highly correlated with cerebral atrophy in brain regions
vulnerable to dementia pathology. When combined in an
automated SVC, and in some cases when applied in isola-
tion, they can be used to achieve diagnostic accuracy
equivalent to, and in some cases better than, unstructured
scan evaluation performed by expert raters. The rating
scales in question are quick and easy to learn and can be
applied, in total, in less than 3min. Taken together, these
results suggest that visual rating scales offer clinicians with-
out expertise in neuroradiology a means of extracting diag-
nostically useful information in a time-efﬁcient and
inexpensive way that is ideally suited for integration into
routine clinical practice.
The ﬁrst aim of this study was to compare the inter-rater
reliability of visual rating scales designed to assess cerebral
atrophy in regions particularly vulnerable to the effects of
dementia pathology. Although reliability is typically re-
ported in the original concept study of each visual rating
scale, and occasionally in follow-up studies, a lack of
standardization in the use and reporting of statistical tech-
niques employed to calculate this metric make it difﬁcult to
make direct comparisons (Harper et al., 2015). In this
study, reliability was investigated using a dataset that is
larger and more representative (through the inclusion of
multiple dementia pathologies and ‘real life’ scans acquired
on multiple scanners over many years) than is typically
used for this purpose. The MTA scale was consistently
highly reliable under all conditions. Of the adapted frontal
scales, reliability was higher between the two raters assess-
ing images from the total study population, than in the
smaller sample rated by four. This difference is likely to
reﬂect both the differences in sample sizes, and that the
two raters (G.F. and L.H.) had more experience with
these scales, suggesting that training may improve reliabil-
ity. The reliability of the AC scale was lower overall, per-
haps reﬂecting the sulcal variability in this rostral region,
which can make it difﬁcult to consistently identify the spe-
ciﬁed region of interest. The PA scale, requiring the inte-
gration of visual information in three planes in four brain
regions (parietal lobe, posterior cingulate sulcus, parieto-
occipital sulcus and precuneus), is undoubtedly the most
difﬁcult to apply. Despite this, the two raters assessing
the total study population achieved a relatively high
degree of reliability, although there was more variability
among the four raters based on the smaller dataset. The
consistently high reliability of the average measures ICC
(based on mean scale scores averaged over raters) perhaps
suggests that where possible, the use of mean scores from
two or more raters may be preferable when practicable.
Using voxel-based morphometry, each of the scales was
remarkably well correlated with the anatomical regions of
interest they were designed to assess, illustrating their re-
gional speciﬁcity. This was particularly true for the MTA
scale, which was highly associated with hippocampal
volume loss, but even the more complex PA scale was
well correlated with the posterior pattern of atrophy it
was designed to detect. Focal atrophy in the small frontal
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Figure 2 Receiver operator characteristic curves of support vector machine performance. Receiver operator characteristic plots of
SVC performance for prediction of primary pathology groups. AUC values with 95% confidence intervals are displayed for each classifier.
AD = Alzheimer’s disease.
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regions assessed by the OF scale, and to a lesser extent the
AC scale (right side only), was also signiﬁcantly correlated
with their associated visual rating scores. While previous
studies have investigated the relationship between rating
scales and brain volumes in the region of interest (Davies
et al., 2009; Shen et al., 2011; Moller et al., 2014), these
results using an unbiased technique provide independent
validation that each of the scales is indeed performing as
predicted. The concordance can also be considered as evi-
dence that voxel-based morphometry (as implemented in
SPM12b) is performing well in this challenging heteroge-
neous dataset.
While several studies have estimated the classiﬁcation ac-
curacy of rating scales in the diagnosis of various dementias
(Scheltens et al., 1992; Galton et al., 2001; Barkhof et al.,
2007; Kipps et al., 2007; Burton et al., 2009; Davies et al.,
2009; Duara et al., 2010; Hornberger et al., 2010; Koedam
et al., 2011; Lehmann et al., 2012; Ambikairajah et al.,
2014; Moller et al., 2014; Harper et al., 2015), very few
have used histopathological diagnosis as the gold standard
(Likeman et al., 2005; Barkhof et al., 2007; Burton et al.,
2009; Lehmann et al., 2012), and to our knowledge no
study has performed this analysis in such a large, clinically
realistic cohort comprising as wide a range of diverse
pathologies and made comparisons with expert scan
assessment.
There were signiﬁcant differences between group mean
scores in both the primary group analysis (Alzheimer’s dis-
ease, DLB, FTLD and control) and the subgroup analysis
(early and late-onset Alzheimer’s disease, DLB, FTLD-Tau,
FTLD-TDP43, younger and older controls) for all visual
rating scales. Speciﬁcally, the early-onset Alzheimer’s dis-
ease and FTLD group scores were signiﬁcantly different
from the younger control group for all scales, reﬂecting
the vulnerability of these regions to dementia pathology.
However, higher scores in the older control group com-
pared to the younger control group, reaching signiﬁcance
in the FI and AT scale (P5 0.05), underline the need to
account for age in the visual assessment of structural brain
imaging. Recent work by Ferreira et al. (2015), and previ-
ous reports from Duara et al. (2013) and Barkhof et al.
(2007) to deﬁne age-speciﬁc cut-offs for the MTA and PA
scales may help to address this issue for these scales, but to
our knowledge similar values have not yet been deﬁned for
the frontal scales. Incorporating the visual rating scale
scores into an automated classiﬁer, however, allows age
to be accounted for more easily (Coupe´ et al., 2012;
Koikkalainen et al., 2012) and removes the requirement
for such cut-offs.
As previous studies have shown, the MTA and PA scales
were the most useful for predicting Alzheimer’s disease
pathology (Scheltens et al., 1992; Burton et al., 2009;
Koedam et al., 2011; Lehmann et al., 2012). The MTA
scale was speciﬁcally useful for late-onset Alzheimer’s dis-
ease, while the PA scale was more useful for younger early-
onset Alzheimer’s disease, which typically results in a
higher proportion of non-amnestic, atypical presentations
(Rossor et al., 2010). Classiﬁcation of the early-onset
Alzheimer’s disease group in comparison with the FTLD
groups, based on the PA scale, was similar to previous re-
ports in the literature [AUC = 0.63 (Tau), AUC = 0.67
(TDP-43) versus AUC = 0.66 (mixed FTLD) (Lehmann et
al., 2012)]. However, in the comparison with the FTLD-
TDP43 group, a higher cut-off score (52.5 versus 52;
Koedam et al., 2011; Lehmann et al., 2012) was required
to provide optimal separation, compromising sensitivity
(22%) at the expense of higher speciﬁcity. Using the
MTA scale, separation of the group of patients with late-
onset Alzheimer’s disease from the DLB group was better
than the equivalent comparison with the early-onset group
using the PA scale (AUC = 0.76 versus 0.66). This result is
in keeping with evidence from previous studies suggesting
that DLB pathology is relatively sparing of the hippocampi
in comparison to Alzheimer’s disease. There was no single
optimal scale for distinguishing between the groups of pa-
tients with FTLD; however, the frontal scales (OF, AC and
FI) were best for distinguishing the FTLD-Tau group, while
temporal scales (AT and MTA) were best for distinguishing
the FTLD-TDP43 group. Using higher OF scale scores to
distinguish between Alzheimer’s disease and FTLD (52.5)
has previously been described by Hornberger et al. (2010)
in a much smaller cohort (AUC = 0.7 versus 0.75 in this
study), however, we also found this scale to be useful in
distinguishing DLB from healthy older controls
(AUC = 0.74). To our knowledge, this is a novel use of
this scale not previously explored in other studies and
echoes ﬁndings in earlier work (Fo¨rstl et al., 1993) of
marked and disproportionate frontal atrophy on CT
images from autopsy conﬁrmed DLB. While in some
cases a single scale produces good classiﬁcation accuracy
for dementia pathology, in most cases, this is greatly im-
proved by combining all scores in an automated classiﬁer,
producing diagnostic accuracy equivalent to, and in some
cases better than, unstructured scan evaluation performed
by dementia experts. Furthermore, accuracy of classiﬁca-
tion based on visual rating is also consistent with the re-
ported accuracies from a previous study using grey matter
volume to distinguish between cases of pathologically con-
ﬁrmed Alzheimer’s disease and FTLD (Whitwell et al.,
2011). Given the ease and accuracy of applying these rat-
ings, this approach provides a potentially valuable way for
non-experts to extract valuable diagnostic information
from routine scans.
While there is considerable interest in using molecular
biomarker techniques to aid in the differential diagnosis,
particularly of Alzheimer’s disease (Ahmed et al., 2014),
it is notable that the classiﬁcation accuracy we report is
comparable to the accuracy of the CSF amyloid-b1-42
level as recently reported in a large sample (balanced ac-
curacy: Alzheimer’s disease from DLB = 64%, Alzheimer’s
disease from FTLD = 81%; Ewers et al., 2015). Although
these tests identify different aspects of the disease process,
and noting that we used only the primary post-mortem
diagnosis excluding co-pathology, each test’s contribution
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to an accurate differential diagnosis is similar. Continued
optimization of the classiﬁer through the inclusion of more
data is likely to improve performance beyond what can be
achieved with simple dichotomization of an individual
scale. While the required level of data to achieve such clas-
siﬁers is unlikely to be available within any single centre,
pooling imaging and pathology data between centres and
making them accessible online to predict pathology from
rating scores could provide a communal resource that is
useful for both research purposes and as a diagnostic aid
in clinic.
This study has a number of strengths including the large
overall sample size, use of multiple scales, post-mortem
conﬁrmation of diagnosis, ‘real life’ acquisition of scans,
and comparisons based on blind assessment, i.e. without
the beneﬁt of clinical information, which in practice is
likely to improve diagnostic performance. Limitations in-
clude the imbalance in the pathology groups, in particularly
the relatively low number of DLB cases included, and the
disproportionate representation of young-onset Alzheimer’s
disease cases compared to the average clinical population.
To obtain sample sizes sufﬁcient for these analyses, we
treated FTLD as a single diagnostic group, and then sub-
divided these cases by primary molecular pathology, how-
ever, further stratiﬁcation and more ﬁne-grained analysis
was not possible. Control subjects were not pathologically
conﬁrmed, therefore, we cannot rule out presymptomatic
pathology in this group, which would result in an under-
estimation of speciﬁcity. However, this does not affect the
more clinically relevant between-pathology group compari-
sons. Whilst the sample size is large in the context of
pathologically conﬁrmed dementias, larger numbers in all
groups would improve statistical certainty, particularly in
the SVC experiments where it is necessary to split the data
into training and testing sets. Greater power could also
allow for more ﬁne-grained analysis of subtypes of the ca-
nonical dementias, and for an investigation of the role of
mixed or multiple pathologies. In terms of expert scan as-
sessment, classiﬁcation performance was based on a subset
of the total study population and assumed to represent as-
sessment of the entire dataset. Visual assessment was also
performed in native space to better reﬂect clinical practice;
however, reorientation to standard space would allow for
greater anatomical consistency between scans and may po-
tentially improve inter-rater reliability and diagnostic accur-
acy. Finally, while the raters participating in this study have
considerable experience in the application of visual rating
scales, it will be of interest to see if similar results can be
obtained in less experienced, or indeed novice raters, and to
assess the effects of training in these individuals.
In summary, this study demonstrates the utility of visual
rating scales to provide diagnostically useful information,
which when considered in the context of a detailed clinical
examination may help to improve the accuracy of clinical
diagnosis for the degenerative dementias. Visual rating
offers a simple and reliable framework to capitalize on
the structural imaging already acquired in most patients
at no extra cost. Until more advanced image analysis tech-
niques are adapted for use in clinical practice, the incorp-
oration of visual rating scales (certainly when combined
with an automated classiﬁer) offers a quick, simple, reliable
means of extracting valuable diagnostic information from
structural brain imaging.
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